Manulife US REIT secures SGX waiver to delay FY2025 results to Mar, 18 2026

SGX Filings
02/25

Manulife US Real Estate Investment Trust said on Feb, 25 2026 that Singapore Exchange Regulation has no objection to its request for an extension until Mar, 18 2026 to release its unaudited financial statements for the year ended Dec, 31 2025, waiving the usual Rule 705(1) deadline.

The trust sought extra time while it negotiates the potential sale of one property. Management believes the agreed sale price would represent the most accurate carrying value for the asset and wants that figure reflected in the upcoming results. If the transaction does not materialise, the accounts will be announced earlier.

The waiver requires the trust to disclose specific information about the extension and to confirm board approval. Manulife US REIT said all waiver conditions have been met.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10